These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19818735)

  • 1. Enhanced chemosensitivity of drug-resistant osteosarcoma cells by lentivirus-mediated Bcl-2 silencing.
    Zhao Y; Zhang CL; Zeng BF; Wu XS; Gao TT; Oda Y
    Biochem Biophys Res Commun; 2009 Dec; 390(3):642-7. PubMed ID: 19818735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced chemosensitivity by simultaneously inhibiting cell cycle progression and promoting apoptosis of drug-resistant osteosarcoma MG63/DXR cells by targeting Cyclin D1 and Bcl-2.
    Zhang C; Zhao Y; Zeng B
    Cancer Biomark; 2012; 12(4):155-67. PubMed ID: 23568006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells.
    Wang G; Rong J; Zhou Z; Duo J
    Mol Biol (Mosk); 2010; 44(6):1010-7. PubMed ID: 21287809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
    Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
    J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells.
    Lima RT; Martins LM; Guimarães JE; Sambade C; Vasconcelos MH
    Cancer Gene Ther; 2004 May; 11(5):309-16. PubMed ID: 15031723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
    Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of cell apoptosis by paclitaxel and pirarubicin in a human osteosarcoma cell line.
    Liu SY; Song SX; Lin L; Liu X
    Chemotherapy; 2010; 56(2):101-7. PubMed ID: 20357441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-alpha enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin by p53-dependent apoptosis.
    Yuan XW; Zhu XF; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
    Acta Pharmacol Sin; 2007 Nov; 28(11):1835-41. PubMed ID: 17959036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous targeting of MCL1 and ABCB1 as a novel strategy to overcome drug resistance in human leukaemia.
    Ji M; Li J; Yu H; Ma D; Ye J; Sun X; Ji C
    Br J Haematol; 2009 Jun; 145(5):648-56. PubMed ID: 19344413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity, expression of Bcl-2 and cell cycle regulation in doxorubicin resistant gastric carcinoma cell lines.
    Yoon KA; Ku JL; Yang JO; Park JG
    Int J Mol Med; 2003 Mar; 11(3):343-8. PubMed ID: 12579337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 gene silencing in pediatric epithelial liver tumors.
    Warmann SW; Frank H; Heitmann H; Ruck P; Herberts T; Seitz G; Fuchs J
    J Surg Res; 2008 Jan; 144(1):43-8. PubMed ID: 17574594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitizing osteosarcoma stem cells to doxorubicin-induced apoptosis through retention of doxorubicin and modulation of apoptotic-related proteins.
    Gonçalves C; Martins-Neves SR; Paiva-Oliveira D; Oliveira VE; Fontes-Ribeiro C; Gomes CM
    Life Sci; 2015 Jun; 130():47-56. PubMed ID: 25818183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a promising new candidate for chemotherapeutic treatment of osteosarcoma patients.
    Pasello M; Hattinger CM; Stoico G; Manara MC; Benini S; Geroni C; Mercuri M; Scotlandi K; Picci P; Serra M
    Eur J Cancer; 2005 Sep; 41(14):2184-95. PubMed ID: 16140527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines.
    Yin JQ; Shen JN; Su WW; Wang J; Huang G; Jin S; Guo QC; Zou CY; Li HM; Li FB
    Acta Pharmacol Sin; 2007 May; 28(5):712-20. PubMed ID: 17439728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted therapy of human osteosarcoma with 17AAG or rapamycin: characterization of induced apoptosis and inhibition of mTOR and Akt/MAPK/Wnt pathways.
    Gazitt Y; Kolaparthi V; Moncada K; Thomas C; Freeman J
    Int J Oncol; 2009 Feb; 34(2):551-61. PubMed ID: 19148492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment of a cisplatin-multidrug resistance cell line of human osteosarcoma].
    Zhang WT; Tu CQ; Liu Y; Li SF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):262-5. PubMed ID: 16608090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro.
    Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q
    Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines.
    Luk F; Yu Y; Walsh WR; Yang JL
    Cancer Invest; 2011 Oct; 29(8):521-32. PubMed ID: 21843050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stathmin is key in reversion of doxorubicin resistance by arsenic trioxide in osteosarcoma cells.
    Feng T; Qiao G; Feng L; Qi W; Huang Y; Yao Y; Shen Z
    Mol Med Rep; 2014 Dec; 10(6):2985-92. PubMed ID: 25310700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to cisplatin and adriamycin is associated with the inhibition of glutathione efflux in MCF-7-derived cells.
    Osbild S; Brault L; Battaglia E; Bagrel D
    Anticancer Res; 2006; 26(5A):3595-600. PubMed ID: 17094488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.